Alexa

Mycamine Manufacturer Settles Whistleblower Lawsuit for $7.3 Million

Astellas Pharma US Settles Mycamine Whistleblower Lawsuit with Federal Government Astellas Pharma US, the pharmaceutical manufacturer behind intravenous antifungal drug Mycamine, has agreed to a $7.3 million settlement in a whistleblower lawsuit related to the drug. The settlement was unsealed on Wednesday, April 16th. Whistleblower Frank Smith … [Read more...]

BestLawyers.comAVBetter Business Bureau